{"name":"Reunion Neuroscience Inc","slug":"reunion-neuroscience-inc","ticker":"","exchange":"","domain":"reunionneuroscience.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE1FMTlyaWFUQVR6TWV6ejZCSHBRN3RNMEJjd3ZvbUlGUEk3WVpVNVhTMWszV0g0QktjeWI5Wm1POTk3RlVjLVFHeVdZQlRrWkpQckU1eGdNRElmazZ6UTYzUVdrX0NFeGoySWxxRldoYURHTlhwRzUwUlBLNm4zUQ?oc=5","date":"2026-02-27","type":"regulatory","source":"The Microdose | Substack","summary":"The FDA is changing the drug approval process; Surgeon General nominee Casey Means asked about psychedelics - The Microdose | Substack","headline":"The FDA is changing the drug approval process; Surgeon General nominee Casey Means asked about psychedelics - The Microd","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxNaldmazNCb1RCRHp2WnVjY19EMWh5R1lvMThKeTMzcHg2ZWdoZWlySlpGbGJ5YjFNUHZYM3lqNW1LblRuNGs4Z0xsMEJRMlFqNkQwd1RSMkc3NFNfWkhaMDh2U3hpMTZ4allfSHl4SW9Zd3VfU3RhdE9qb09vZlVJRTlzQ05SdjV0NmxyM2Z4R3hEc0FzSFN6MzJTcFJGMUJtWm9vTGJ1RXk4S2dXcjZjaDhfX3p4Ymx3c00zQ2JESGd1Zm9WcVVKLXdmeXhxSmNENndZOGhoTmZ1a3U1WWEyMWRpamlvN0UtVHBDMVJfaFJGSFRUTGs0THdocw?oc=5","date":"2026-02-23","type":"regulatory","source":"GlobeNewswire","summary":"U.S. FDA Grants Reunion Neuroscience’s Luvesilocin (RE104) Breakthrough Therapy Designation Status - GlobeNewswire","headline":"U.S. FDA Grants Reunion Neuroscience’s Luvesilocin (RE104) Breakthrough Therapy Designation Status","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNclZCb1ZxMWFSR0FJVHloYUNzUDdqOXRNaU5CS0tTT0ZYRS1TYnllOTdSYlBPZFh3SjVvVUhzRTVnNEtoQjJBZVAzRGhYWXJHRmRxdHRHbE5WTEstVThydjBGMzc4ZlpFdEZvaGtKZGVFUm53ZGRHcE1pRnlGWlozUjY2X0VSYTlxYTYzY1NGaExmbzBGT0ZHSFFjY3ZvQzFM?oc=5","date":"2025-08-25","type":"pipeline","source":"BioPharma Dive","summary":"AbbVie wagers more than $1B on Gilgamesh’s psychedelic drug - BioPharma Dive","headline":"AbbVie wagers more than $1B on Gilgamesh’s psychedelic drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNQldpd2tWS2NMN0pfcGd3S0dCM3lUT3l6SUthN2JKcEtTaVpTS1dqVk5LbTVGY2lFZWcwaFc4Wms2VkpuS0NyYTZEZGNkdU5GMnR0UFR1c2JUQngyZF83cWNKeGhxSWx5aHkzOTFPZWR5N2E3TzJnaXh6YmVqMkNqOTdMNU13Y0gzWVI4Uy05MFRiSi1RZnY3SklrOEhkOXhsV2c?oc=5","date":"2025-08-18","type":"pipeline","source":"BioPharma Dive","summary":"Reunion’s psychedelic drug headed to late-stage testing - BioPharma Dive","headline":"Reunion’s psychedelic drug headed to late-stage testing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwJBVV95cUxNZlROV01oUE1NS3l6bUttWWI0a1lvZHdCTW1PSV9iNFlVRmNpSG9xTFpmTGQtUHlaTmMzd2l4Y256bFZJS3lzS3lDWFBfY0NDY1FVSGZUSDlGR25pZ3Nib2gwU1hWem9oR19Yc1ZQX0FySlhndkk4cUd6dFBkdm1mVmxaMU5ObHZJbzdQWmlCT0VSaktEMFZLTGxMYnBJRkVGN25yOUFES3U3cHd0eWNjVWNHMUhjX3RtWG1GVXRiSkhHUUtnM1l2a24xckpVR1dOM3hXQlJGa3FDUjRJNTV5cWdiUzR4YktUbTY0cXhkbkdWV3BxMTFQWGo0T3NnOTZ5MWxIZDUtVER3aEpJYXlHRnl6aU1NVklFUnNVajRTVmxFblZGUHV1anJkQk42cF9WUXVUU0ktVEtlSmlrR1EzcElPbw?oc=5","date":"2025-08-18","type":"trial","source":"GlobeNewswire","summary":"Reunion Neuroscience Announces Positive Topline Results from RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression (PPD) - GlobeNewswire","headline":"Reunion Neuroscience Announces Positive Topline Results from RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOR2lGcGZfb3FYWjRaTUhsQnZuZFlTaUJUU2xwY2l1MWtEdWFNQWV1eVhTNnlZejdRbUsxazZlcXJERUdTVGd0bmIzS0hMTmt4RDRUQWc4TlE2ODh3TjFncHprbHFRbmZrOXpmVUhkY1JHT0FadmNOTElZU2Z5UlRaSkdQMlhNQjVLQzBHYWpFY0RjVW9rSnZMQUtHV09tVkZVazMxRzlwdnZ3TzAxeXEtWQ?oc=5","date":"2025-07-28","type":"pipeline","source":"Contract Pharma","summary":"ReAlta Life Sciences Names Ellen Lubman as Chief Business Officer - Contract Pharma","headline":"ReAlta Life Sciences Names Ellen Lubman as Chief Business Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQX0NMTkpRanlRZFhWQjZFLXg5RjBxTUlRSnVrZkRBeUJXSkZKTUMxNG9xVEk0TWJ0Q0NSdVJDeFU1cE96WEJxVUI4N3J6M0x1NUNjZzZvdU41dTRQTG5IakFkMjhCdVFMYXNWU21UVFcwU3ZaSU5DVXU3NDBpU0c0c1pNR09raUMzaTQwalB4MnpaREJOcm9JZTMtTlhCNmJwWXNodk9wMWZEeXo0b3NyVzVZVEhxNDA?oc=5","date":"2025-07-02","type":"regulatory","source":"Healio","summary":"Psychedelics may improve psychotherapy outcomes, but obstacles remain - Healio","headline":"Psychedelics may improve psychotherapy outcomes, but obstacles remain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBuN251RWN5ZTdTNkg0SFhJU1RhTmFqeFFfQ1M5NVkxdTlRZzM2ek1ibzNWN0hMRlFtRnNwMUhpNEpNdlFPRGhmTWhrSk0wWVZpQXZv?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"REUN Stock Price, News & Analysis | Reunion Neuroscience - Stock Titan","headline":"REUN Stock Price, News & Analysis | Reunion Neuroscience","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNRWtWS3pPdVVOUGN6bjEyMzNyRnM3OUMxQ3dONUlOZjRic0ZUMnJVLVRidFFZN1dkOE9nMHFRS1F5c3p0SHAwOXl6MGRWbWcxdWkwZXpIbjlicFh5MW5XX1A5ODR1eUxEakR3bnF6d0lkdjUwSFRQZV9YSzlZTE0yRngxdmNHVjF5WThPSEVIWXdKSW93UTdjLXFOMmZjUQ?oc=5","date":"2024-12-17","type":"pipeline","source":"Psychiatrist.com","summary":"RE104 Offers a Revolutionary Approach to Postpartum Depression - Psychiatrist.com","headline":"RE104 Offers a Revolutionary Approach to Postpartum Depression","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxQYXVhRmo2YzloYmxXQzNaR0ZHVkNnbUhvdV94bXk1ZjFIRHRMdm96eTBRQU04eEJKaHFydThELTVpZnhCZFZSQVdJUXJFMGFvV0hsNHVfZ0tNRXlfRWpUMDl4NlF0Vy1DSnRRT1d2SVgyenI2c29LcTZsLXlzUkJ1RFlkal9TQ3c3X1RGd093eUsza0pKWXBfc3lmX2FodThaendBRzI5UG1sbmJsYzJkM29xdkpUSnkyMWtJeHplTVliMGowMVoxOG52TWdteFdoNGhkbFJCRDRKQThDWmtidzNfMEcwNjhRUE1HNE5ZWQ?oc=5","date":"2024-05-19","type":"trial","source":"2 Minute Medicine","summary":"Reunion Neuroscience: Psychedelic Prodrug RE104 For The Treatment of Post-Partum Depression Moves Into Phase 2 Clinical Trials. - 2 Minute Medicine","headline":"Reunion Neuroscience: Psychedelic Prodrug RE104 For The Treatment of Post-Partum Depression Moves Into Phase 2 Clinical ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNRWYtQW1Pd1g4OGpGSjBqa0VoZUlWbGg4QzJLUnNfRUNrV1RJSHoxektiaXJ5MDlhaXlJV0F5bUtUNkJDQ2lBV2JqSENYTEdzZldVMjRQYnhOcHc2Z2ZzakJhMnZTRUdzcGpFMVNOTWNaSHFtMWxnUFdnUXN4eGVVRUZZa0xHYjBjeHFUZw?oc=5","date":"2024-05-02","type":"pipeline","source":"Yahoo Finance","summary":"Reunion Neuroscience Inc. Announces $103 Million Series A Financing Co-Led by MPM BioImpact and Novo Holdings - Yahoo Finance","headline":"Reunion Neuroscience Inc. Announces $103 Million Series A Financing Co-Led by MPM BioImpact and Novo Holdings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQVGUxbGhxMHVZbEYwQ3ZhY1R2aEVpdEM4aG1mdHZXUDFETlowb0VPM25VRDhVVzhkRFJWTzVGRnZGNVY4YjcyRnV3ZXhKMTRhVnU5Y212SUVwOEItTkxHQl9Da0daT1lqUDdSR1dWSlhES2QwSU9kSmdPMUlYb1loLWdQcjNjSW12UlRJTU1Ic2w1T1VNZ0xSc1Z3TC1FbFJjU3BReHBPeE16dVU?oc=5","date":"2023-03-17","type":"pipeline","source":"Mugglehead Magazine","summary":"Reunion Neuroscience files lawsuit against Mindset Pharma for copying drug compound - Mugglehead Magazine","headline":"Reunion Neuroscience files lawsuit against Mindset Pharma for copying drug compound","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}